Re:GPT‑Rosalind for life sciences research
by XenophileJKO on Thursday April 16, 2026 @10:56PM
(#47802026)
I would argue that while you still have failed trials, then we have room to improve trial vetting.
[ Parent
| on HN ]
There are no comments on this comment yet.